CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea
Moo Hyun Lee, Wonshik Han, Jeong Eon Lee, Ku Sang Kim, Heeseung Park, Jongjin Kim, Soo Youn Bae, Hyun Joo Shin, Jong Won Lee, Eun Sook Lee
Cancer Research and Treatment. 2015;47(2):208-214.   Published online 2014 September 11    DOI:

Excel Download

Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
SpringerPlus. 2014;3(1):   Crossref logo
Link1 Link2 Link3

Poor concordance between 21-gene expression assay recurrence score and all Magee equation recurrence scores in a consecutive cohort of patients treated for hormone receptor positive early breast cancer
The Breast. 2017;32:S87   Crossref logo
Link1 Link2

Clinical relevance of the 21-gene Recurrence Score® assay in treatment decisions for patients with node-positive breast cancer in the genomic era
npj Breast Cancer. 2018;4(1):   Crossref logo
Link1 Link2 Link3

The 21-gene Recurrence Score: Impact on Adjuvant Chemotherapy Decisions in Early Breast Cancer, West of Scotland Cancer Centre Experience
Clinical Oncology. 2017;29(6):e101   Crossref logo
Link1 Link2

P200 Impact of the 21-gene recurrence score assay on treatment decision in early breast cancer (EBC) patients with favourable prognostic factors
The Breast. 2011;20:S44   Crossref logo
Link1 Link2

Clinical utility of the 21-gene Oncotype DX® Recurrence Score® (RS) assay in hormone receptor-positive, HER2-negative breast cancer (BC)
The Breast. 2017;32:S97   Crossref logo
Link1 Link2

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer
npj Breast Cancer. 2021;7(1):   Crossref logo
Link1 Link2 Link3

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
Breast Cancer Research and Treatment. 2013;140(1):83-92   Crossref logo
Link1 Link2 Link3

Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
Journal of the Egyptian National Cancer Institute. 2020;32(1):   Crossref logo
Link1 Link2 Link3

Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage breast cancer (ESBC) patients
The Breast. 2019;44:S16   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.